title: Dietary citrate treatment of polycystic kidney disease in rats.
abstract: Progression of autosomal-dominant polycystic kidney disease (ADPKD) in the heterozygous male Han:SPRD rat is dramatically slowed by ingestion of potassium or sodium citrate. This study examined the efficacy of delayed therapy with sodium citrate, the effect of sodium citrate therapy on kidney cortex levels of transforming growth factor-beta (TGF-beta), and the response to calcium citrate ingestion. Rats were provided with citrate salts in their food, and renal clearance, blood pressure, blood chemistry, and survival determinations were made. Sodium citrate therapy was most effective when started at age 1 month, and delay of therapy until age 3 months produced no benefit. Kidney cortex TGF-beta levels were elevated in 3- and 8-month-old rats with ADPKD, but not in 6-week-old rats. Sodium citrate treatment, started at age 1 month, lowered TGF-beta levels to normal in 3-month-old rats, but this is probably not the primary mechanism of citrate's beneficial effect. Calcium citrate had only a modest effect in preserving glomerular filtration rate. Effective treatment of ADPKD in this rat model requires early administration of a readily absorbed alkalinizing citrate salt. Existing data on ADPKD patients on vegetarian diets or with kidney stones should be studied in light of these findings.
authors.affiliation: Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, Ind 46202, USA. gtanner@iupui.edu
authors.forename: George A
authors.initials: GA
authors.lastname: Tanner
authors.forename: Judith A
authors.initials: JA
authors.lastname: Tanner
mesh_terms: D000818:Animals; D020296:Animals, Congenic; D002118:Calcium / Q000097:blood / Q000652:urine; D019355:Calcium Citrate / Q000097:blood / Q000627:therapeutic use / Q000652:urine; D002951:Citrates / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D003404:Creatinine / Q000097:blood; D004195:Disease Models, Animal; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D007672:Kidney Cortex / Q000737:chemistry / Q000473:pathology / Q000502:physiology; D008297:Male; D016891:Polycystic Kidney, Autosomal Dominant / Q000097:blood / Q000178:diet therapy* / Q000652:urine; D051381:Rats; D017207:Rats, Sprague-Dawley; D000077559:Sodium Citrate; D016212:Transforming Growth Factor beta / Q000378:metabolism; D014508:Urea / Q000097:blood; D014556:Urine / Q000737:chemistry
chemical_list: D002951:Citrates; D016212:Transforming Growth Factor beta; D000077559:Sodium Citrate; D014508:Urea; D003404:Creatinine; D019355:Calcium Citrate; D002118:Calcium